nach oben

Diabetology International

Erschienen in:

27.06.2020 | Original Article

Evaluation of some oxidative markers in diabetes and diabetic retinopathy

verfasst von: Hadeel Ahmed Shawki, Rasha Elzehery, Maha Shahin, Ekbal M. Abo-hashem, Magdy M. Youssef

Erschienen in: Diabetology International | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Aims

Diabetes mellitus and diabetic retinopathy (DR) are major public health concerns globally. Oxidative stress plays a central role in the pathogenesis of diabetes and DR. The aim of this study was to investigate the association of malondialdehyde, uric acid and bilirubin with diabetes and diabetic retinopathy development.

Methods

This study was conducted on 110 diabetics (with and without retinopathy). Beside 40 healthy individuals as a control group. The level of three markers (malondialdehyde, uric acid and bilirubin) was estimated in the studied groups. Receiver operating characteristic analysis and a logistic regression model was performed.

Results

The present study revealed significantly higher uric acid and malondialdehyde levels, while bilirubin showed significantly lower levels in diabetics compared to control and similarly in diabetic retinopathy compared to those without DR. Furthermore, combination of the three markers increased the accuracy and effect size for differentiation between diabetes with and without DR. In addition, higher levels of uric acid and malondialdehyde were associated with risk of diabetes and DR development.

Conclusion

This study concluded that higher levels of uric acid and malondialdehyde were associated with increase in the risk of diabetes and DR development, while bilirubin wasn’t associated with decreasing the risk of diabetes or DR. However, the combination of malondialdehyde, uric acid and bilirubin may be a valuable addition to the current options for the prognosis of DR. In addition, malondialdehyde may be independent predictor of diabetes and DR as well as uric acid may be used as independent biomarker to predict the risk of DR.

Kurup R, Ansari AA, Singh J. Review A review on diabetic foot challenges in Guyanese perspective. Diabetes Metabol Syndrome Clin Rese Rev. 2019;13(2):905–12. https://doi.org/10.1016/j.dsx.2018.12.010.CrossRef

Abbasa SAN, Razaa ST, Mird SS, et al. Association of variants rs7903146 and rs290487 of TCF7L2 gene with diabetic nephropathy and co-morbidities (hypertension and dyslipidemia) in type 2 diabetes mellitus. Meta Gene. 2019;20:1–7. https://doi.org/10.1016/j.mgene.2019.100561.CrossRef

Rahimi-Madiseh M, Malekpour-Tehrani A, Bahmani M, et al. The research and development on the antioxidants in prevention of diabetic complications. Asian Pac J Trop Med. 2016;9(9):825–31. https://doi.org/10.1016/j.apjtm.2016.07.001.CrossRefPubMed

Kaur N, Vanita V. Association analysis of PPARγ (p.Pro12Ala) polymorphism with type 2 diabetic retinopathy in patients from north India. Ophthalm Genet. 2017;38(3):217–21. https://doi.org/10.1080/13816810.2016.1193879.CrossRef

Frazaoa LB, Theera-Umpona N, Auephanwiriyakul S. Diagnosis of diabetic retinopathy based on holistic texture and local retinal features. Inf Sci. 2019;475:44–66. https://doi.org/10.1016/j.ins.2018.09.064.CrossRef

Korany MA, Sonbol A, Elgouhary SM. Omentin-1 and diabetic retinopathy in type 2 diabetic patients. Alexandria J Med. 2018;54:323–6. https://doi.org/10.1016/j.ajme.2018.04.003.CrossRef

Cecilia OM, José Alberto CG, José NP, et al. Oxidative stress as the main target in diabetic retinopathy pathophysiology. J Diabetes Res. 2019;2019:8562408. https://doi.org/10.1155/2019/8562408.CrossRefPubMedPubMedCentral

Fonseca I. Malondialdehyde as a biomarker in kidney transplantation. Biomarkers in disease: methods, discoveries and applications. Biomark Kidney Dis. 2015;1:1–25. https://doi.org/10.1007/978-94-007-7743-9.CrossRef

Ren Y, Gao L, Guo X, et al. Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China. J Diabetes Compl. 2018;32(11):1000–5. https://doi.org/10.1016/j.jdiacomp.2018.09.002.CrossRef

10.

Manickam S, Arun P, Petchiappan V, et al. Is serum uric acid an added risk factor for micro-vascular complications of diabetes mellitus?—a prospective study. Int J Contemp Med Res. 2019;6(7):30–3. https://doi.org/10.21276/ijcmr.2019.6.7.20.CrossRef

11.

Zhu B, Wu X, Ning K, et al. The negative relationship between bilirubin level and diabetic retinopathy: a meta analysis. PLoS ONE. 2016;11(8):1–16. https://doi.org/10.1371/journal.pone.0161649.CrossRef

12.

Prabhavathi K, Kunder M, Shashidhar KN, et al. Serum total bilirubin levels in diabetic retinopathy—a case control study. IOSR J Pharm. 2013;4(8):1–6. https://doi.org/10.9790/3013-04080106.CrossRef

13.

Abraham EC, Huff TA, Cope ND, et al. Determinations of the glycosylated hemoglobins (HbA1) with a new micro-column procedure. Diabetes. 1978;27(9):931–7. https://doi.org/10.2337/diab.27.9.931.CrossRefPubMed

14.

Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis. 2003;41(1):1–12. https://doi.org/10.1053/ajkd.2003.50007.CrossRefPubMed

15.

Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90(1):37–433. https://doi.org/10.3995/jstroke.1.313.CrossRefPubMed

16.

Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–31. https://doi.org/10.1016/0076-6879(90)86135-i.CrossRefPubMed

17.

Fossati P, Prencipe L, Berti G. Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem. 1980;26(2):227–31. https://doi.org/10.1093/clinchem/26.2.227.CrossRefPubMed

18.

Jendrassik L, Grof P. Colorimetric method of determination of bilirubin. Biochem Z. 1938;297:81–2.

19.

Salgado JF. Transforming the area under the normal curve (AUC) into Cohen’s d, Pearson’s rpb, odds-ratio, and natural log odds-ratio: two conversion tables. Eur J Psychol Appl Legal Context. 2018;10(1):35–47. https://doi.org/10.5093/ejpalc2018a5.CrossRef

20.

Cohen J. A power primer. Psychol Bull. 1992;112:155–9. https://doi.org/10.1037//0033-2909.112.1.155.CrossRefPubMed

21.

Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77. https://doi.org/10.1111/ceo.12696.CrossRefPubMed

22.

Ahsan H. Diabetic retinopathy-biomolecules and multiple pathophysiology. Diabetes Metab Syndr. 2015;9:51–4. https://doi.org/10.1016/j.dsx.2014.09.011.CrossRefPubMed

23.

Du Y, Veenstra A, Palczewski K, et al. Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci. 2013;110(41):16586–91. https://doi.org/10.1073/pnas.1314575110.CrossRefPubMedPubMedCentral

24.

Dave A, Kalra P, Gowda BR, et al. Association of bilirubin and malondialdehyde levels with retinopathy in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2015;19(3):373–7. https://doi.org/10.4103/2230-8210.152777.CrossRefPubMedPubMedCentral

25.

Tseng ST, Chou ST, Low BH, et al. Risk factors associated with diabetic retinopathy onset and progression in diabetes patients: a Taiwanese cohort study. Int J Clin Exp Med. 2015;8(11):21507–15.PubMedPubMedCentral

26.

Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280. https://doi.org/10.1136/bmjopen-2017-016280.CrossRefPubMedPubMedCentral

27.

Jihan AM, Seham MA, Hamdia EA, et al. Relationship between diabetic retinopathy and methylenetetrahydrofolate reductase gene polymorphism. Egypt J Hosp Med. 2017;67(2):628–34. https://doi.org/10.12816/0037814.CrossRef

28.

Chutani A, Pande S. Correlation of serum creatinine and urea with glycemic index and duration of diabetes in Type 1 and Type 2 diabetes mellitus: a comparative study. Natl J Physiol Pharm Pharmacol. 2017;7(9):914–9. https://doi.org/10.5455/njppp.2017.7.0515606052017.CrossRef

29.

Elhefnawy KA, Elsayed AM. Prevalence of diabetic kidney disease in patients with type 2 diabetes mellitus. Egypt J Internal Med. 2019;31(2):149–54. https://doi.org/10.4103/ejim.ejim_113_18.CrossRef

30.

Kaewput W, Thongprayoon C, Rangsin R, et al. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: a multicenter nationwide cross-sectional study. World J Nephrol. 2019;8(2):33–43. https://doi.org/10.5527/wjn.v8.i2.33.CrossRefPubMedPubMedCentral

31.

Kawasaki R, Kitano S, Sato Y, et al. Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetol Int. 2019;10(1):3–11. https://doi.org/10.1007/s13340-018-0357-z.CrossRefPubMed

32.

Nair A, Nair BJ. Comparative analysis of the oxidative stress and antioxidant status in type II diabetics and nondiabetics: a biochemical study. J Oral Maxillofac Pathol. 2017;21(3):394–401. https://doi.org/10.4103/jomfp.JOMFP_56_16.CrossRefPubMedPubMedCentral

33.

Al-Duais MA, Sakran MI, Shalaby KA, et al. Diagnostic value of serum adenosine deaminase in type II Saudi diabetic patients. Adv Diabetes Endocrinol. 2015;1(1):5. https://doi.org/10.13188/2475-5591.1000001.CrossRef

34.

Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—a concise review. Saudi Pharm J. 2016;24(5):547–53. https://doi.org/10.1016/j.jsps.2015.03.013.CrossRefPubMed

35.

Dos Santos JM, Tewari S, Mendes RH. The role of oxidative stress in the development of diabetes mellitus and its complications. J Diabetes Res. 2019;2019:4189813. https://doi.org/10.1155/2019/4189813.CrossRefPubMedPubMedCentral

36.

Xiong Q, Liu J, Xu Y. Effects of uric acid on diabetes mellitus and its chronic complications. Int J Endocrinol. 2019;2019:9691345. https://doi.org/10.1155/2019/9691345.CrossRefPubMedPubMedCentral

37.

Chen YY, Kao TW, Yang HF, et al. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects—an observational study. Clin Chim Acta. 2018;478:68–73. https://doi.org/10.1016/j.cca.2017.12.038.CrossRefPubMed

38.

Chang JB, Chen YL, Hung YJ, et al. The role of uric acid for predicting future metabolic syndrome and type 2 diabetes in older people. J Nutr Health Aging. 2017;21(3):329–35. https://doi.org/10.1007/s12603-016-0749-3.CrossRefPubMed

39.

Wang T, Bi Y, Xu M, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine. 2011;40(1):109–16. https://doi.org/10.1007/s12020-011-9449-2.CrossRefPubMed

40.

Haque T, Rahman S, Islam S, et al. Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals. Diabetol Metab Syndr. 2019;11(1):49. https://doi.org/10.1186/s13098-019-0446-6.CrossRefPubMedPubMedCentral

41.

Cheriyath P, Gorrepati VS, Peters I, et al. High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999–2006. J Clin Med Res. 2010;2(5):201–6. https://doi.org/10.4021/jocmr425w.CrossRefPubMedPubMedCentral

42.

Yang M, Ni C, Chang B, et al. Association between serum total bilirubin levels and the risk of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2019;152:23–8. https://doi.org/10.1016/j.diabres.2019.04.033.CrossRefPubMed

43.

Altoum AEA, Osman AL, Babker AM. Correlation of oxidative stress markers malondialdehyde (MDA), antioxidant vitamins A, E, and C with glycated hemoglobin (HBA1C) levels in Type 2 diabetes mellitus. Asian J Pharm Clin Res. 2018;11(5):281–3. https://doi.org/10.22159/ajpcr.2018.v11i5.24548.CrossRef

44.

Shaikh S, Memon A, Ata MA, et al. Association of serum bilirubin, serum malondialdehyde and glycemic control with retinopathy in type 2 diabetic subjects. Int J Diabetes Endocrinol. 2017;2(1):10–4. https://doi.org/10.11648/j.ijde.20170201.13.CrossRef

45.

Zarei M, Farahnak Z, Hosseinzadeh-Attar MJ, et al. Lipid peroxidation and antioxidant enzymes activity in controlled and uncontrolled Type 2 diabetic patients. ARYA Atheroscler. 2016;12(3):118–23.PubMedPubMedCentral

46.

Fadhel AA, Yousif AK. Correlation of glycated hemoglobin (Hba1c) and serum uric acid in type-2 diabetic patients. Indian J Public Health Res Dev. 2019;10(5):1250–4. https://doi.org/10.5958/0976-5506.2019.01167.7.CrossRef

47.

Wei F, Chang B, Yang X, et al. Serum uric acid levels were dynamically coupled with hemoglobin A1c in the development of type 2 diabetes. Sci Rep. 2016;6(1):1–9. https://doi.org/10.1038/srep28549.CrossRef

48.

Karuppannasamy D, Venkatesan R, Thankappan L, et al. Inverse association between serum bilirubin levels and retinopathy in patients with type 2 diabetes mellitus. J Clin Diagn Res. 2017;11(2):NC09–NC12. https://doi.org/10.7860/JCDR/2017/24259.9452.CrossRefPubMedPubMedCentral

49.

Farasat T, Sharif S, Manzoor F, et al. Serum bilirubin is significantly associated with HbA1C in type 2 diabetic subjects. Endocrinol Metab Inter J. 2017;5(6):338–41. https://doi.org/10.15406/emij.2017.05.00142.CrossRef

50.

Shrivastav C, Parekh PA, Kumar GI. A correlative study of body mass index with oxidative stress parameters (serum uric acid and serum malondialdihyde) in essential hypertension. Int J Res Med Sci. 2019;7(4):1252–6. https://doi.org/10.18203/2320-6012.ijrms20191334.CrossRef

51.

Ferreira TDS, Fernandes JFR, Araújo LDS, et al. Serum uric acid levels are associated with cardiometabolic risk factors in healthy young and middle-aged adults. Arq Bras Cardiol. 2018;111(6):833–40. https://doi.org/10.5935/abc.20180197.CrossRefPubMedPubMedCentral

52.

An H, Du X, Huang X, et al. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients. Transl Psychiatry. 2018;8(1):1–7. https://doi.org/10.1038/s41398-018-0303-7.CrossRef

53.

Tabatabaei-Malazy O, Khodaeian M, Bitarafan F, et al. Polymorphisms of antioxidant genes as a target for diabetes management. Int J Mol Cell Med. 2017;6(3):135–47. https://doi.org/10.22088/acadpub.BUMS.6.3.135.CrossRefPubMedPubMedCentral

54.

Wu SS, Kor CT, Chen TY, et al. Relationships between serum uric acid, malondialdehyde levels, and carotid intima-media thickness in the patients with metabolic syndrome. Oxidat Med Cell Longev. 2019;2019:6859757. https://doi.org/10.1155/2019/6859757.CrossRef

55.

Dulull N, Kwa F, Osman N, et al. Recent advances in the management of diabetic retinopathy. Drug Discov Today. 2019;24(8):1499–509. https://doi.org/10.1016/j.drudis.2019.03.028.CrossRefPubMed

56.

Verma MK, Singh SP, Alam R, et al. Comparative study on MDA, SOD and HbA1c levels in patients of type 2 diabetes mellitus with retinopathy and without retinopathy. Int J Pharm Sci Res. 2016;7(10):4184–90. https://doi.org/10.13040/IJPSR.0975-8232.CrossRef

57.

Inoguchi T, Sonoda N, Maeda Y. Bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes: a new aspect on old molecule. Diabetol Int. 2016;7(4):338–41. https://doi.org/10.1007/s13340-016-0288-5.CrossRefPubMedPubMedCentral

58.

Zhu B, Wu X, Ning K, et al. The negative relationship between bilirubin level and diabetic retinopathy: a meta-analysis. PLoS ONE. 2016;11(8):e0161649. https://doi.org/10.1371/journal.pone.0161649.CrossRefPubMedPubMedCentral

59.

Kumawat M, Kharb S, Singh V, et al. Plasma malondialdehyde (MDA) and anti-oxidant status in diabetic retinopathy. J Indian Med Assoc. 2014;112(1):29–322. https://doi.org/10.1007/s12291-008-0035-1.CrossRefPubMed

60.

Kundu D, Mandal T, Mausumi N, et al. Oxidative stress in diabetic patients with retinopathy. Ann Afr Med. 2014;13(1):41–6. https://doi.org/10.4103/1596-3519.126951.CrossRefPubMed

61.

Sekioka R, Tanaka M, Nishimura T, et al. Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus. J Diabetes Compl. 2015;29(2):218–21. https://doi.org/10.1016/j.jdiacomp.2014.12.002.CrossRef

62.

Sekioka R, Tanaka M, Nishimura T, et al. Low serum total bilirubin concentration in patients with type 1 diabetes mellitus complicated by retinopathy and nephropathy. Diabetol Int. 2015;6(4):300–5. https://doi.org/10.1007/s13340-014-0201-z.CrossRef

63.

Yasuda M, Kiyohara Y, Wang JJ, et al. High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. Ophthalmology. 2011;118(7):1423–8. https://doi.org/10.1016/j.ophtha.2010.12.009.CrossRefPubMed

64.

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2(17):1–25. https://doi.org/10.1186/s40662-015-0026-2.CrossRef

65.

Senthilvel V, Radhakrishnan R, Sathiyamoorthi R, et al. A study on finding influencing factors on diabetic retinopathy among diabetic patients using Multiple Regression approach. IOSR J Dent Med Sci. 2012;1(4):20–3. https://doi.org/10.9790/0853-0142023.CrossRef

66.

Hoque S, Muttalib MA, Islam MI, et al. Evaluation of HbA1c level and other risk factors in diabetic retinopathy: a study of type 2 diabetic patients attending in a tertiary level hospital. KYAMC J. 2016;6(2):614–9. https://doi.org/10.3329/kyamcj.v6i2.33738.CrossRef

67.

Magliah SF, Bardisi W, Al Attah M, et al. The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals. J Fam Med Prim Care. 2018;7(5):975–81.

Titel: Evaluation of some oxidative markers in diabetes and diabetic retinopathy
verfasst von: Hadeel Ahmed Shawki
Rasha Elzehery
Maha Shahin
Ekbal M. Abo-hashem
Magdy M. Youssef
Publikationsdatum: 27.06.2020
Verlag: Springer Singapore
Erschienen in: Diabetology International / Ausgabe 1/2021
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-020-00450-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Evaluation of some oxidative markers in diabetes and diabetic retinopathy

Abstract

Aims

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

A case of an elderly patient with insulin-dependent diabetes and dementia receiving one basal insulin plus one bolus insulin injections a day for 6 months

Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway

Recurrent hyperglycemic hyperosmolar state after re-administration of dose-reduced ceritinib, an anaplastic lymphoma kinase inhibitor

Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society

FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients

Characteristics of patients who developed glucose intolerance in the early period after partial pancreatectomy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin